Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve and take on record the ....
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brooks Laboratories Ltd has scheduled a Board meeting on Friday, 29th May 2026 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2026 (Q4 FY2026 results). This is a standard regulatory intimation under SEBI Listing Regulations. The company also confirmed that the trading window has been closed since 1st April 2026 for directors, designated persons, and their relatives, and will reopen 48 hours after the results are declared — a standard insider trading safeguard ahead of a material announcement.
The 29th May meeting is expected to release Q4 and full-year FY2026 results, which could impact the stock price. Investors should note that company insiders remain restricted from trading until 48 hours post-result declaration.